Agrivida completes initial close of $20m in funding

Company prepares for commercialization of its patented GRAINZYME feed enzyme.

Agrivida Inc., an agritech company focused on animal nutrition, announced that it has completed an initial close of $20.4 million in Series E financing.

The funds will be used to advance the commercialization of Agrivida’s patented GRAINZYME feed additive enzymes for use with poultry and swine and to support product development for dairy and beef cattle. The University of Texas Investment Management Co. led the round and was joined by current investors ARCH Venture Partners, Cultiv

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.

Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)

Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit and click on Subscribe at the top of the page for more information.



Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.